Access to Medicines… Can Countries use TRIPS Article 30 to take Unilateral Action to Address COVID Vaccine shortages? 22 Feb 2021 (For a longer treatment on the availability of unilateral measures under TRIPS, I recommend Chapter 6 of my PhD Climate Change, Technology Transfer and Intellectual Property: Options for Action at…
Access to Medicines… Is COVID Manufacturing Capacity actually limited or is Intellectual Property the problem? 19 Feb 2021 Supply of the Moderna and BioNTech/Pfizer (and others) vaccines is likely not to keep up with the supply commitments made by both companies. News reports suggest that they are only…
Technology, Sustainability & Human Rights 